Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-02-23 @ 9:22 PM
Study NCT ID:
NCT02187133
Status:
COMPLETED
Last Update Posted:
2021-04-23
First Post:
2014-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-08
First Submit QC Date:
None
Study First Post Date:
2014-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-21
Last Update Post Date:
2021-04-23
Last Update Post Date Type:
ACTUAL